Zobrazeno 1 - 10
of 13
pro vyhledávání: ''
Autor:
Cathrine Widehammar, Katarzyna Kulbacka-Ortiz, Karin Eriksson, Anita Stockselius, Helena Burger, Zdenka Pihlar, Max Ortiz-Catalan, Kerstin Caine-Winterberger, Alejandra Zepeda-Echavarria, Rannveig A Guðmundsdóttir, Morten B Kristoffersen, Liselotte Hermansson, Christina Ragnö
Publikováno v:
The Lancet. 388:2885-2894
Summary Background Phantom limb pain is a debilitating condition for which no effective treatment has been found. We hypothesised that re-engagement of central and peripheral circuitry involved in motor execution could reduce phantom limb pain via co
Autor:
K Hunter, Dennis Chan, Richard Nicholas, Virginia L. Calder, Jennifer M. Nicholas, Nick C. Fox, Shona Clegg, Jeremy Chataway, Val Anderson, David Wilkie, John Greenwood, Chris Frost, David G. MacManus, Charles R. M. Bangham, A Alsanousi, Casper Nielsen, Nadine Schuerer
Publikováno v:
The Lancet. 383(9936):2213-2221
Summary Background Secondary progressive multiple sclerosis, for which no satisfactory treatment presently exists, accounts for most of the disability in patients with multiple sclerosis. Simvastatin, which is widely used for treatment of vascular di
Autor:
Ana-Belén Perona-Moratalla, Blanca Eulalia Fuentes Gimeno, Tomás Segura, Oscar Ayo-Martin, José Ferro, Ana Rodríguez Campello, Jose Alvarez-Sabin, Elsa Azevedo, Peter Ringleb, Vítor Tedim Cruz, Jose Castillo, Jose Egido, Gemma Serrano-Heras, Exuperio Diez Tejedor, María del Mar Castellanos, Erik Cobo, Joan Montaner, Joan Martí-Fàbregas, Natalia Pérez de la Ossa, Eduardo Martinez-Vila, Álvaro Ximénez-Carrillo Rico, Adrià Arboix
Publikováno v:
The Lancet. 380:349-357
Summary Background Citicoline is approved in some countries for the treatment of acute ischaemic stroke. The drug has shown some evidence of efficacy in a pooled analysis. We sought to confirm the efficacy of citicoline in a larger trial. Methods We
Autor:
Alice B. Gottlieb, Stephen K. Tyring, Deepa Lalla, Angelika Jahreis, David Cella, Craig L. Leonardi, Ranga Krishnan, Ralph Zitnik, Michael Woolley, Kim A. Papp, Andrea Wang, Kenneth B. Gordon
Publikováno v:
The Lancet. 367:29-35
Psoriasis has substantial psychological and emotional effects. We assessed the effect of etanercept, an effective treatment for the clinical symptoms of psoriasis, on fatigue and symptoms of depression associated with the condition.618 patients with
Publikováno v:
The Lancet. 358:787-790
Functional disability is generally caused by hemiplegia after stroke. Physiotherapy used to be the only way of improving motor function in such patients. However, administration of amphetamines in addition to exercise improves motor recovery in anima
Autor:
Mitchell A. Nides, BD Jamerson, Sonia Buist, MK Patel, G Dozier, Richard E. Kanner, David Gonzales, Donald P. Tashkin, P Anderson, William C. Bailey
Publikováno v:
The Lancet. 357:1571-1575
Summary Background Tobacco smoking is associated with chronic obstructive pulmonary disease (COPD) in more than 80% of cases. Our aim was to investigate the effect of sustained-release bupropion (amfebutamone) (SR) in promoting abstinence from smokin
Autor:
Maria Carla Roncaglioni
Publikováno v:
The Lancet. 357:89-95
Summary Background In addition to the treatment of specific cardiovascular risk factors, intervention which interferes with the general mechanisms of atherosclerosis could further reduce the incidence of cardiovascular events. We aimed to investigate
Autor:
Chanaka Dahanayake, Andrew P. Cope, Ian C. Scott, Margaret H. Y. Ma, Seth D. Seegobin, David Scott, Cathryn M. Lewis
Publikováno v:
The Lancet. 383:S95
Background UK guidelines recommend that all patients with early active rheumatoid arthritis are offered combination disease-modifying anti-rheumatic drugs (DMARDs) and short-term corticosteroids. This heterogeneous disease has several subsets; one cr
Publikováno v:
The Lancet. 370:1606
1should be commended on their study focusing on warfarin versus aspirin therapy in people older than 75 years. Although the study showed that those prescribed warfarin had fewer episodes of major bleeds than those taking aspirin, participant selectio
Autor:
Jack Hirsh, J.J. Morgan, G.S. Hale, J.C. Biggs, C.N. Chesterman, E.F. O'Sullivan, I G McDonald, M. Rosenbaum, J.H.N. Bett, P.A. Castaldi, K.H. Mclean, J.P. Isbister
Publikováno v:
The Lancet. 301:57-60
In a multicentre controlled trial 517 patients with the clinical diagnosis of myocardial infarction within the preceding 24 hours were admitted to coronary-care units, and allocated at random to receive streptokinase followed by heparin and warfarin